Combination therapy involving bispecific binding agents binding to cldn18.2 and cd3 and anti-vegfr2 antibodies
IL328456APending Publication Date: 2026-07-01ASTELLAS PHARMA INC +2
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- IL · IL
- Patent Type
- Applications
- Current Assignee / Owner
- ASTELLAS PHARMA INC
- Filing Date
- 2026-05-14
- Publication Date
- 2026-07-01
Need to check novelty before this filing date? Find Prior Art
No text content released.